Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
16-18 November 2027
Congress Center HamburgHamburg, Germany

Dr. Daniel Waschke, PhD
Associate Regulatory Program Director at F. Hoffmann-La Roche Ltd.
Speaker

Profile

Daniel is a Regulatory Program Director at Roche, bringing over 15 years of pharmaceutical industry experience dedicated exclusively to CMC regulatory affairs. He began his career at Bachem before joining Roche in 2017. While his background spans synthetic molecules across all stages of development, from early clinical trials through to commercialization, he has focused heavily on oligonucleotides and peptides since 2022. Beyond that, Daniel actively contributes to industry-wide harmonization as a member of EFPIA and EPOC workstreams. He holds a PhD in Organic Chemistry from the University of Hamburg

Agenda Sessions

  • Chairperson’s Remarks: Regulatory CMC Strategies for Oligonucleotides

    , 08:00